{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:44:35Z","timestamp":1773150275670,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.brainres.2008.07.015","type":"journal-article","created":{"date-parts":[[2008,7,13]],"date-time":"2008-07-13T04:05:39Z","timestamp":1215921939000},"page":"16-24","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in na\u00efve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone"],"prefix":"10.1016","volume":"1231","author":[{"given":"Stanley M.","family":"Crain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Fei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2008.07.015_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of \u03bc- and \u03b4-opioid receptor antagonists","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0024-3205(82)90174-6","article-title":"Caffeine stimulates \u03b2-endorphin release in blood but not in cerebrospinal fluid","volume":"31","author":"Arnold","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib3","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1073\/pnas.96.9.5280","article-title":"Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway","volume":"96","author":"Bach","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2008.07.015_bib4","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2008.07.015_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1523\/JNEUROSCI.06-01-00127.1986","article-title":"Immunoreactive dynorphin B in sacral primary afferent fibers of the cat","volume":"6","author":"Basbaum","year":"1986","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2008.07.015_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.185694","article-title":"Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness","volume":"194","author":"Bloom","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.brainres.2008.07.015_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0092-8674(01)00629-8","article-title":"DREAM is a critical transcriptional repressor for pain modulation","volume":"108","author":"Cheng","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2008.07.015_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jpain.2005.01.356","article-title":"Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of oxytrex","volume":"6","author":"Chindalore","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.brainres.2008.07.015_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/249471a0","article-title":"Quasi-morphine-abstinence syndrome","volume":"249","author":"Collier","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2008.07.015_bib10","first-page":"1513","article-title":"Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines","volume":"40","author":"Collier","year":"1981","journal-title":"FASEB"},{"key":"10.1016\/j.brainres.2008.07.015_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-6147(90)90322-Y","article-title":"Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons","volume":"11","author":"Crain","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(92)90417-8","article-title":"After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside","volume":"575","author":"Crain","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib13","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.92.23.10540","article-title":"Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance\/dependence during chronic cotreatment","volume":"92","author":"Crain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2008.07.015_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0165-6147(98)01241-3","article-title":"Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions","volume":"19","author":"Crain","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1998.tb09665.x","article-title":"GM1 ganglioside-induced modulation of opioid receptor-mediated functions","volume":"845","author":"Crain","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3959(99)00223-7","article-title":"Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance\/dependence liability","volume":"84","author":"Crain","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2008.07.015_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(00)03010-9","article-title":"Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia","volume":"888","author":"Crain","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2003.09.068","article-title":"Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice","volume":"995","author":"Crain","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2007.06.058","article-title":"Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naive mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice","volume":"1167","author":"Crain","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(86)91105-4","article-title":"Cyclic AMP or forskolin rapidly attenuates the depressant effects of opioids on sensory-evoked dorsal-horn responses in mouse spinal cord-ganglion explants","volume":"370","author":"Crain","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0885-3924(03)00139-8","article-title":"Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone","volume":"25","author":"Cruciani","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.brainres.2008.07.015_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0702601","article-title":"Pharmacological modulation of secondary mediator systems\u2013cyclic AMP and cyclic GMP\u2013on inflammatory hyperalgesia","volume":"127","author":"Cunha","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib23","first-page":"1496","article-title":"Low and high frequency electroacupuncture stimulation release [Met5]enkephalin and dynorphin A in rat spinal cord","volume":"32","author":"Fei","year":"1987","journal-title":"Chin. Sci. Bull."},{"key":"10.1016\/j.brainres.2008.07.015_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0090-6980(79)90103-5","article-title":"I-prostaglandin hyperalgesia. A cAMP\/Ca++ dependent process","volume":"18","author":"Ferreira","year":"1979","journal-title":"Prostaglandins"},{"key":"10.1016\/j.brainres.2008.07.015_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0014-2999(84)90575-2","article-title":"Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes","volume":"102","author":"Fournie-Zaluski","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0304-3959(84)90049-6","article-title":"Dynorphin: potent mediator for electroacupuncture analgesia in spinal cord of the rabbit","volume":"40","author":"Han","year":"1984","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2008.07.015_bib27","first-page":"336","article-title":"Cyclic adenosine monophosphate antagonism of morphine analgesia","volume":"185","author":"Ho","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2008.07.015_bib28","first-page":"496","article-title":"Cyclic AMP, morphine, Met-enkephalin and neuronal firing","volume":"219","author":"Hosford","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2008.07.015_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainres.2008.07.015_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00504987","article-title":"Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord","volume":"327","author":"Jurna","year":"1984","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0006-8993(89)90974-8","article-title":"Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin degrading enzymes) systemically administered in normal and arthritic rats","volume":"497","author":"Kayser","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00314807","article-title":"Pharmacokinetics of (+)-rolipram and (\u2212)-rolipram in healthy volunteers","volume":"38","author":"Krause","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3959(02)00486-4","article-title":"Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone","volume":"104","author":"Le Guen","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2008.07.015_bib34","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1073\/pnas.73.8.2895","article-title":"\u03b2-Endorphin is a potent analgesic agent","volume":"73","author":"Loh","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2008.07.015_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14728222.11.2.145","article-title":"Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs","volume":"11","author":"Noble","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.brainres.2008.07.015_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0306-4522(94)00397-N","article-title":"Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat","volume":"64","author":"Ouseph","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2008.07.015_bib37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2008.07.015_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-6147(00)01571-6","article-title":"Novel approaches to targeting neuropeptide systems","volume":"21","author":"Roques","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib39","series-title":"Discovery of Novel Opioid Medications. Vol. 147","first-page":"104","article-title":"Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction","author":"Roques","year":"1995"},{"key":"10.1016\/j.brainres.2008.07.015_bib40","series-title":"Opioids in Pain Control","first-page":"21","article-title":"Endogenous opioid peptides and analgesia","author":"Roques","year":"1999"},{"key":"10.1016\/j.brainres.2008.07.015_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-540-33823-9_1","article-title":"Peripheral and central mechanisms of pain generation","volume":"177","author":"Schaible","year":"2007","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib42","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1471-4159.1986.tb01787.x","article-title":"Direct demonstration of the activation of UDP-N-acetylgalactosamine:[GM3]N-acetylgalactosaminyltransferase by cyclic AMP","volume":"4","author":"Scheideler","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2008.07.015_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(89)90059-0","article-title":"Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture","volume":"491","author":"Shen","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(90)90868-C","article-title":"Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors","volume":"525","author":"Shen","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)90751-V","article-title":"Cholera toxin-B subunit blocks opioid excitatory effects on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions","volume":"531","author":"Shen","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib46","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1523\/JNEUROSCI.14-09-05570.1994","article-title":"Nerve growth factor rapidly prolongs the action potential of mature sensory neurons in culture and this effect requires activation of Gs-coupled excitatory kappa opioid receptors on these cells","volume":"14","author":"Shen","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2008.07.015_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(97)00197-2","article-title":"Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance\/dependence in mice","volume":"757","author":"Shen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(01)02990-0","article-title":"Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance\/dependence","volume":"919","author":"Shen","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5055\/jom.2006.0044","article-title":"Ultra-low-dose opioid antagonists to enhance opioid analgesia","volume":"2","author":"Sloan","year":"2006","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.brainres.2008.07.015_bib50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.bjp.0701486","article-title":"Activation of the cAMP transduction cascade contributes to the mechanical hyperalgesia and allodynia induced by intradermal injection of capsaicin","volume":"122","author":"Sluka","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2008.07.015_bib51","first-page":"648","article-title":"Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices","volume":"264","author":"Suarez-Roca","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2008.07.015_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(95)11721-8","article-title":"Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons","volume":"194","author":"Suarez-Roca","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2008.07.015_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0306-4522(91)90255-M","article-title":"Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia","volume":"44","author":"Taiwo","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2008.07.015_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0306-4522(89)90280-7","article-title":"Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system","volume":"32","author":"Taiwo","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2008.07.015_bib55","series-title":"Manual of Pharmacologic Calculation With Computer Programs","author":"Tallarida","year":"1987"},{"key":"10.1016\/j.brainres.2008.07.015_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)90613-1","article-title":"Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?","volume":"18","author":"Teixeira","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2008.07.015_bib57","doi-asserted-by":"crossref","unstructured":"Tsai, R.Y., Jang, F.L., Tai, Y.H., Lin, S.L., Shen, C.H., Wong, C.S., in press. Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats. Neuropsychopharmacology.","DOI":"10.1038\/sj.npp.1301672"},{"key":"10.1016\/j.brainres.2008.07.015_bib58","series-title":"The Pharmacology of Opioid Peptides","first-page":"249","article-title":"Mechanisms of \u03b2-endorphin-induced antinociception","author":"Tseng","year":"1995"},{"key":"10.1016\/j.brainres.2008.07.015_bib59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.brainres.2008.07.015_bib60","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1523\/JNEUROSCI.21-05-01779.2001","article-title":"Pronociceptive actions of dynorphin maintain chronic neuropathic pain","volume":"21","author":"Wang","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2008.07.015_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.06.003","article-title":"Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbg signaling","volume":"135","author":"Wang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2008.07.015_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0169-328X(96)00281-1","article-title":"Interaction of \u03b4-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode","volume":"44","author":"Wu","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainres.2008.07.015_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1749-6632.1998.tb09666.x","article-title":"The role of GM1 ganglioside in regulating excitatory opioid effects","volume":"845","author":"Wu","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308016727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899308016727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T12:45:26Z","timestamp":1557665126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899308016727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":63,"alternative-id":["S0006899308016727"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2008.07.015","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}